ADC Landscape Webinar
The momentum of ADCs has continued to assert its dominance in the oncology field throughout 2023, with a huge influx of new developers entering the space and numerous shifts in focus across payloads, combination trials, and Bispecific ADCs. In our recent webinar, we invited attendees to explore the traditional and novel ADC landscapes to maximize their pipelines and discover new opportunities that show huge potential to accelerate drug development.
We asked:
The total number of ADC programs has more than doubled in the last 2 years, what are the emerging trends from this recent influx of activity?
From Payloads, Linkers, and Targets, to Bispecifics and Combinations, which approaches are seeing the most use and having the most impact across the ADC space?
What were the key highlights and updates for ADC development across 2023?
Our Experts
Jia He
House Speaker
ADC Senior Research Lead
Beacon
Jake Morris
Moderator
Account Manager
Beacon
You May Also Be Interested In…
Navigating Payload Innovation and Toxicity Trends in ADC Development
Access Webinar
Drug Payload Quantification in LNPs with New Scatter-Free Absorption
Access WebinarLearn More About ADC
- The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
- Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
